Well, I have lots of questions. Is Dr. Mullan as CEO of Archer Pharmaceuticals using or benefiting for research done at RCPI on "our" (common shareholders) dime? Where is Ryan Lanier who was Chief Science Officer at RCPI now? (his LinkedIn still shows him in position at RCPI...I guess he has not updated). Ted Jenkins is now working for CrossBio Development, LLC. Still have to believe that the people that did the last financing expect to realize at least something from the IP sale. Who is working on establishing value of the sale?
News 
Market Data 
Discover 
